RxDoctor Payments Data

Michael Noone

Otolaryngology · Charleston, SCNPI 1376500504

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Stryker at 35.6% of the total. 2025 is the largest year on record at $311, 3.5 times the $89 reported in 2019. That places this record below the midpoint for otolaryngology clinicians in SC, where the typical reported total is $1,243.

$638in general payments, 2019–2025

Across 18 payments — averaging $35.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$227
  • Neurent Medical Limited$114
  • Genentech USA, Inc.$79
  • Kaleo, Inc.$50
  • Intersect ENT, Inc.$42
  • Alk-abello, Inc$41
  • plus $85 from 4 others
$32,760in ownership & investment interests, 2019–2025

Across 7 payments — averaging $4680.00 each. An ownership or investment interest held by the physician or an immediate family member.

  • The North Carolina Mutual Wholesale Drug Company Inc$33K

What the payments were for

  • Food & beverage$638100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$638 in reported general payments places this provider in the 35th percentile of 180 otolaryngology providers in South Carolina.

See all otolaryngology providers in South Carolina

Medicare billing

Part B allowed, 2024
$199,705
Medicare patients
650
Services billed
2,440

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Epinephrine15$2,925
Fluticasone Propionate193$2,758
Azelastine Hcl111$2,679
Ipratropium Bromide61$1,758
Omeprazole133$1,433
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth11$1,193
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav56$775
Doxycycline Hyclate26$491
Clotrimazole11$400
Ofloxacin20$368
Montelukast Sodium35$295
Cefdinir12$282
Nystatin17$254
Mupirocin19$157
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim18$117

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →